top

  Info

  • Utilizzare la checkbox di selezione a fianco di ciascun documento per attivare le funzionalità di stampa, invio email, download nei formati disponibili del (i) record.

  Info

  • Utilizzare questo link per rimuovere la selezione effettuata.
Advances in the Treatment of Renal Cell Carcinoma
Advances in the Treatment of Renal Cell Carcinoma
Autore Reynolds Paul
Pubbl/distr/stampa Basel, : MDPI - Multidisciplinary Digital Publishing Institute, 2022
Descrizione fisica 1 online resource (221 p.)
Soggetto topico Medicine
Soggetto non controllato artesunate (ART)
autophagy
biomarker
biomarkers
ccRCC
chloroquine
clear cell renal cell carcinoma
cysteine cathepsin inhibitors
cysteine cathepsins
evolution
evolutionary trajectory
ferroptosis
genomic signature
growth inhibition
hydroxychloroquine
immune checkpoint inhibitors
immune-based combination therapies
immunotherapy
individualization
kidney cancer
lysosome
metastatic
metastatic renal cell carcinoma
mRCC
network meta-analysis
PD-L1
predictive
RCC
reactive oxygen species (ROS)
renal cancer
renal cell cancer
renal cell carcinoma
renal cell carcinoma (RCC)
ROC-325
second line therapy
soluble factors
sunitib resistance
TKIs
Traditional Chinese Medicine (TCM)
transcriptomic analysis
treatment
tyrosine kinase inhibitors
Formato Materiale a stampa
Livello bibliografico Monografia
Lingua di pubblicazione eng
Record Nr. UNINA-9910557615503321
Reynolds Paul  
Basel, : MDPI - Multidisciplinary Digital Publishing Institute, 2022
Materiale a stampa
Lo trovi qui: Univ. Federico II
Opac: Controlla la disponibilità qui
Botulinum Toxin Treatment for Pain and Inflammation in Functional Urological Disorders
Botulinum Toxin Treatment for Pain and Inflammation in Functional Urological Disorders
Autore Kuo Hann-Chorng
Pubbl/distr/stampa Basel, Switzerland, : MDPI - Multidisciplinary Digital Publishing Institute, 2020
Descrizione fisica 1 online resource (196 p.)
Soggetto topico Medicine and Nursing
Soggetto non controllato antimuscarinics
benign prostatic hyperplasia
bladder
bladder pain
botulinum toxin
Botulinum toxin
botulinum toxin A
chronic pelvic pain syndrome
chronic prostatitis
diabetes mellitus
drug delivery
functional urological disorders
functional urology disorder
human
hydrodistention
inflammation
interstitial cystitis
lower urinary tract symptoms
maximal bladder capacity
mid-urethral sling
molecular mechanism
network meta-analysis
neurogenic detrusor overactivity
onabotulinumtoxinA
OnabotulinumtoxinA
overactive bladder
pain
painful bladder syndrome
pathophysiology
pelvic pain
peripheral tibial nerve stimulation
predictor
prostatitis
sacral neuromodulation
sensation
therapeutic outcome
therapy
treatment
urethra
urethral sphincter
urethral sphincter dysfunction
urinary incontinence
urodynamics
voiding
Formato Materiale a stampa
Livello bibliografico Monografia
Lingua di pubblicazione eng
Record Nr. UNINA-9910557297603321
Kuo Hann-Chorng  
Basel, Switzerland, : MDPI - Multidisciplinary Digital Publishing Institute, 2020
Materiale a stampa
Lo trovi qui: Univ. Federico II
Opac: Controlla la disponibilità qui
Non-small Cell Lung Cancer: Current Therapies and New Targeted Treatments
Non-small Cell Lung Cancer: Current Therapies and New Targeted Treatments
Autore Uchino Junji
Pubbl/distr/stampa Basel, Switzerland, : MDPI - Multidisciplinary Digital Publishing Institute, 2021
Descrizione fisica 1 online resource (258 p.)
Soggetto topico Medicine
Soggetto non controllato adjuvant chemotherapy
biomarker
chemotherapy
daily practice
DNA polymerase beta
docetaxel
EGFR-TKI
endocrine disorders
epidermal growth factor receptor
Expanded Access Program
FDG-PET
genomic diagnosis
glucose transporter 1
HIP1R
immune checkpoint inhibitor
immune checkpoint inhibitors
immune-related adverse events
immunotherapy
interstitial lung disease
KRAS
lung cancer
lung neoplasms
meta-analysis
metastasis
methylation
multiple cancers
mutation
network meta-analysis
nivolumab
non-small cell lung cancer
non-small-cell lung cancer
nonsmall cell lung cancer
NSCLC
nucleotide-diphosphate kinase
oligometastasis
osimertinib
PD-1
PD-1 blockade
PD-1 inhibitors
PD-L1
PD-L1 expression
PD-L1 inhibitors
phase I/II trial
platinum-based first-line
predictive biomarker
previously treated patients
prognosis
prognostic factor
prognostic factors
pulmonary fibrosis
pulmonary pleomorphic carcinoma
RAD51B methylation
radiology and other imaging
real-world data
rechallenge
recurrence
responsiveness
retrospective analysis
RUNX1
S-1
salvage surgery
sequencing
stage IIIA-N2
surgery
survival
T790M
targeted therapy
TP53 mutations
tumor-bearing patients
tyrosine kinase inhibitors
unresectable
β-catenin
Formato Materiale a stampa
Livello bibliografico Monografia
Lingua di pubblicazione eng
Altri titoli varianti Non-small Cell Lung Cancer
Record Nr. UNINA-9910557489703321
Uchino Junji  
Basel, Switzerland, : MDPI - Multidisciplinary Digital Publishing Institute, 2021
Materiale a stampa
Lo trovi qui: Univ. Federico II
Opac: Controlla la disponibilità qui